Other Events ·
Shuttle Pharmaceuticals Holdings, Inc. received a notification from Nasdaq on August 28, 2026, indicating…
SHPHShuttle Pharmaceuticals Holdings, Inc.
Shuttle Pharmaceuticals Holdings, Inc. received a notification from Nasdaq on August 28, 2026, indicating noncompliance with Listing Rule 5250(c)(1) due to the delayed filing of its Form 10-Q for the period ended June 30, 2026. The company has until October 27, 2026, to submit a compliance plan and may receive an extension until February 22, 2027, if accepted. Failure to regain compliance could result in delisting from Nasdaq. Shuttle Pharmaceuticals Holdings, Inc. operates in the pharmaceutical technology sector, utilizing AI-driven platforms for molecular discovery and early-stage drug development.